All ATR Content

AptarGroup, Inc (ATR) Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

AptarGroup, Inc (NYSE: ATR) FY 2026 Other Release

March 20, 20261 min read

AptarGroup, Inc (ATR) Sec Form 8K

AptarGroup, Inc (NYSE: ATR) Sec Form 8K

March 18, 20261 min read

AptarGroup, Inc (ATR) Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

AptarGroup, Inc (NYSE: ATR) FY 2026 Management Update

March 17, 20261 min read

AptarGroup, Inc (ATR) Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN Nasal Spray

AptarGroup, Inc (NYSE: ATR) FY 2026 Other Release

March 16, 20261 min read

AptarGroup, Inc (ATR) Q4 2025 Earnings Call Transcript

AptarGroup, Inc (NYSE: ATR) Q4 2025 Earnings Call dated Feb. 06, 2026 Corporate Participants: Mary Skafidas — Senior Vice President,...

March 10, 202647 min read

AptarGroup, Inc (ATR) The Raymond James 2026 Institutional Investors Conference

AptarGroup, Inc (NYSE: ATR) FY 2026 Corporate Conference

February 18, 20261 min read

AptarGroup, Inc (ATR) The Bank of America Securities 2026 Global Agriculture and Materials Conference

AptarGroup, Inc (NYSE: ATR) FY 2026 Corporate Conference

February 18, 20261 min read

AptarGroup, Inc (ATR) Sec Form 10K

AptarGroup, Inc (NYSE: ATR) Sec Form 10K

February 7, 20261 min read

AptarGroup, Inc (ATR) Sec Form 8K

AptarGroup, Inc (NYSE: ATR) Sec Form 8K

February 6, 20261 min read

Analysis

AptarGroup, Inc. (ATR) Shares Rise on Q4 Revenue Beat Amid Margin Pressure

Shares of AptarGroup, Inc. (ATR) advanced modestly following the release of fourth-quarter and full-year 2025 results on February 5, 2026,...

February 6, 20263 min read